Physician profile
John J Leppard
NPI 1184647497
$660.52
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $101 · 2021: $116 · 2022: $22.40 · 2023: $147 · 2024: $97.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $244.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $289.08 | 2019-2024 | Exogen Ultrasound Bone Healing System, Durolane, Durolane |
| Depuy Synthes Sales INC. | $101.56 | 2019-2024 | Orthovisc, Monovisc |
| Ferring Pharmaceuticals INC. | $92.62 | 2021-2023 | Euflexxa |
| Baxter Healthcare | $47.37 | 2020-2021 | |
| Endo Pharmaceuticals INC. | $38.52 | 2019 | |
| Acumed LLC | $37.89 | 2019 | |
| Horizon Therapeutics Plc | $31.29 | 2020 | |
| Baudax Bio INC. | $22.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Leppard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.